Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue $ 3,375 $ 3,756
Cost of revenue 1,569 1,805
Gross profit 1,806 1,951
Operating expenses:    
Sales and marketing 1,707 1,818
Research and development 988 1,136
General and administrative 2,551 2,253
Total operating expenses 5,246 5,207
Loss from operations (3,440) (3,256)
Other income (expense), net:    
Interest expense, net (72) (57)
Gain on revaluation of warrant liabilities 1 342
Loss on modification of warrant 0 (109)
Unrealized gain (loss) on foreign exchange 626 (349)
Other expense, net (6) 0
Total other income (expense), net 549 (173)
Net loss (2,891) (3,429)
Other comprehensive (loss) income (533) 291
Comprehensive loss $ (3,424) $ (3,138)
Net loss per share applicable to common stockholders, basic and diluted (in dollars per share) $ (0.12) $ (0.2)
Weighted average number of common shares outstanding, basic and diluted (in shares) 25,393 17,419